# Sprout Social timeline entity: /record/sprout-social.md id: ent_sprout-social ## undated - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_062C0E67BE38](/claim/clm_062C0E67BE38.md) - undated | cik | 0001517375 | valid | [clm_233A30FC1537](/claim/clm_233A30FC1537.md) - undated | listed_on | Nasdaq | valid | [clm_54DF93AC69E0](/claim/clm_54DF93AC69E0.md) - undated | fiscal_year_end | 12-31 | valid | [clm_64E4F33DC339](/claim/clm_64E4F33DC339.md) - undated | ticker | SPT | valid | [clm_7304A4290454](/claim/clm_7304A4290454.md) - undated | registrant_name | Sprout Social, Inc. | valid | [clm_7E19B9BE24D2](/claim/clm_7E19B9BE24D2.md) - undated | state_of_incorporation | DE | valid | [clm_8E7AF7F4322F](/claim/clm_8E7AF7F4322F.md) ## 2009 - 2009-05-01 | x_username | sproutsocial | unverified | [clm_9D800893823C](/claim/clm_9D800893823C.md) ## undated - undated | website | http://sproutsocial.com/ | unverified | [clm_1A4478AE3658](/claim/clm_1A4478AE3658.md) - undated | country | United States | unverified | [clm_9244DE2C993E](/claim/clm_9244DE2C993E.md) ## 2017 - 2017-12-31 to 2018-12-31 | total_equity | -56,468,000 United States dollar | superseded | [clm_ED75F7B69FFD](/claim/clm_ED75F7B69FFD.md) ## 2018 - 2018-12-31 to 2019-03-31 | total_equity | 25,733,000 United States dollar | superseded | [clm_13E470601C14](/claim/clm_13E470601C14.md) - 2018-12-31 to 2019-12-31 | research_and_development | 25,426,000 United States dollar | superseded | [clm_15ACB01D3C3F](/claim/clm_15ACB01D3C3F.md) - 2018-12-31 to 2019-12-31 | net_income | -20,934,000 United States dollar | superseded | [clm_9C9AD9FCEEEC](/claim/clm_9C9AD9FCEEEC.md) - 2018-12-31 to 2019-12-31 | operating_income | -20,772,000 United States dollar | superseded | [clm_B60B4DC491C6](/claim/clm_B60B4DC491C6.md) - 2018-12-31 to 2019-12-31 | revenue | 78,813,000 United States dollar | superseded | [clm_B6760D7EE0AB](/claim/clm_B6760D7EE0AB.md) ## 2019 - 2019-03-31 to 2019-06-30 | quarterly_revenue | 23,379,000 United States dollar | superseded | [clm_29E85BF5C4F9](/claim/clm_29E85BF5C4F9.md) - 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 6,352,000 United States dollar | superseded | [clm_828B4FD9B4C5](/claim/clm_828B4FD9B4C5.md) - 2019-03-31 to 2019-06-30 | quarterly_net_income | -5,163,000 United States dollar | superseded | [clm_9E974BB3063C](/claim/clm_9E974BB3063C.md) - 2019-03-31 to 2019-06-30 | quarterly_operating_income | -5,354,000 United States dollar | superseded | [clm_C410EBF3D81A](/claim/clm_C410EBF3D81A.md) - 2019-03-31 to 2019-06-30 | total_equity | 20,576,000 United States dollar | superseded | [clm_E449F05AC767](/claim/clm_E449F05AC767.md) - 2019-06-30 to 2019-09-30 | quarterly_revenue | 24,763,000 United States dollar | superseded | [clm_31E6C4F77C18](/claim/clm_31E6C4F77C18.md) - 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 6,424,000 United States dollar | superseded | [clm_3A4908203C45](/claim/clm_3A4908203C45.md) - 2019-06-30 to 2019-09-30 | quarterly_operating_income | -10,880,000 United States dollar | superseded | [clm_54BE33EFE4DB](/claim/clm_54BE33EFE4DB.md) - 2019-06-30 to 2019-09-30 | quarterly_net_income | -10,755,000 United States dollar | superseded | [clm_58D8FCA7A990](/claim/clm_58D8FCA7A990.md) - 2019-06-30 to 2019-09-30 | total_equity | 12,813,000 United States dollar | superseded | [clm_76A5FE3DA99F](/claim/clm_76A5FE3DA99F.md) - 2019-09-30 to 2019-12-31 | total_equity | 7,856,000 United States dollar | superseded | [clm_55474F9B4B8E](/claim/clm_55474F9B4B8E.md) - 2019-09-30 to 2020-03-31 | quarterly_operating_income | -5,119,000 United States dollar | superseded | [clm_61AAFC93019B](/claim/clm_61AAFC93019B.md) - 2019-09-30 to 2020-03-31 | quarterly_net_income | -5,039,000 United States dollar | superseded | [clm_AC76565C0825](/claim/clm_AC76565C0825.md) - 2019-09-30 to 2020-03-31 | quarterly_revenue | 26,421,000 United States dollar | superseded | [clm_CB0738D0E0F2](/claim/clm_CB0738D0E0F2.md) - 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 6,361,000 United States dollar | superseded | [clm_F3CB29A65B79](/claim/clm_F3CB29A65B79.md) - 2019-12-31 to 2020-12-31 | revenue | 102,707,000 United States dollar | superseded | [clm_1C8D1E3220B9](/claim/clm_1C8D1E3220B9.md) - 2019-12-31 to 2020-12-31 | research_and_development | 28,059,000 United States dollar | superseded | [clm_4353C0FBA8D9](/claim/clm_4353C0FBA8D9.md) - 2019-12-31 to 2020-03-31 | total_assets | 189,591,000 United States dollar | superseded | [clm_4F7060051DA4](/claim/clm_4F7060051DA4.md) - 2019-12-31 to 2020-12-31 | operating_income | -47,268,000 United States dollar | superseded | [clm_831867E76D21](/claim/clm_831867E76D21.md) - 2019-12-31 to 2020-03-31 | total_equity | 128,130,000 United States dollar | superseded | [clm_A984CC907CB1](/claim/clm_A984CC907CB1.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 135,310,000 United States dollar | superseded | [clm_AA72C18ABE01](/claim/clm_AA72C18ABE01.md) - 2019-12-31 to 2020-12-31 | net_income | -46,807,000 United States dollar | superseded | [clm_F5F4EE6F04BC](/claim/clm_F5F4EE6F04BC.md) ## 2020 - 2020-03-31 to 2020-06-30 | total_equity | 127,970,000 United States dollar | superseded | [clm_0CC6D42C3E7E](/claim/clm_0CC6D42C3E7E.md) - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 7,281,000 United States dollar | superseded | [clm_36208014B67F](/claim/clm_36208014B67F.md) - 2020-03-31 to 2020-06-30 | total_assets | 198,526,000 United States dollar | superseded | [clm_5B55CC3D91FF](/claim/clm_5B55CC3D91FF.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | -10,480,000 United States dollar | superseded | [clm_657860E1F8D9](/claim/clm_657860E1F8D9.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 30,535,000 United States dollar | superseded | [clm_8D7D87F15FB4](/claim/clm_8D7D87F15FB4.md) - 2020-03-31 to 2020-06-30 | cash_and_equivalents | 137,376,000 United States dollar | superseded | [clm_B231E3BE2B82](/claim/clm_B231E3BE2B82.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | -10,944,000 United States dollar | superseded | [clm_CBEAC86E2782](/claim/clm_CBEAC86E2782.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 7,712,000 United States dollar | superseded | [clm_084706F6FADA](/claim/clm_084706F6FADA.md) - 2020-06-30 to 2020-09-30 | total_assets | 191,836,000 United States dollar | superseded | [clm_76CEEFEAA841](/claim/clm_76CEEFEAA841.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | -8,302,000 United States dollar | superseded | [clm_9A32C95BEB1D](/claim/clm_9A32C95BEB1D.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | -8,342,000 United States dollar | superseded | [clm_BB083A171A2F](/claim/clm_BB083A171A2F.md) - 2020-06-30 to 2020-09-30 | total_equity | 119,034,000 United States dollar | superseded | [clm_D786954B9CCA](/claim/clm_D786954B9CCA.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 31,402,000 United States dollar | superseded | [clm_FB28E594B6D8](/claim/clm_FB28E594B6D8.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 79,792,000 United States dollar | superseded | [clm_FD86CBDADA4A](/claim/clm_FD86CBDADA4A.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 7,693,000 United States dollar | superseded | [clm_070C6576D402](/claim/clm_070C6576D402.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | -6,997,000 United States dollar | superseded | [clm_3729161DDFE0](/claim/clm_3729161DDFE0.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 33,666,000 United States dollar | superseded | [clm_46B1CC5C7442](/claim/clm_46B1CC5C7442.md) - 2020-09-30 to 2020-12-31 | total_assets | 232,252,000 United States dollar | superseded | [clm_80AF054149A0](/claim/clm_80AF054149A0.md) - 2020-09-30 to 2020-12-31 | total_equity | 156,615,000 United States dollar | superseded | [clm_B895493FFB1F](/claim/clm_B895493FFB1F.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | -6,921,000 United States dollar | superseded | [clm_C4E753D9B379](/claim/clm_C4E753D9B379.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 117,778,000 United States dollar | superseded | [clm_CACA05F40FCF](/claim/clm_CACA05F40FCF.md) - 2020-12-31 to 2021-12-31 | net_income | -31,655,000 United States dollar | superseded | [clm_07172E923E1B](/claim/clm_07172E923E1B.md) - 2020-12-31 to 2021-12-31 | revenue | 132,949,000 United States dollar | superseded | [clm_0FFF58157D59](/claim/clm_0FFF58157D59.md) - 2020-12-31 to 2021-03-31 | total_assets | 239,669,000 United States dollar | superseded | [clm_452B4775627F](/claim/clm_452B4775627F.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 114,515,000 United States dollar | superseded | [clm_905A6F9B0BCF](/claim/clm_905A6F9B0BCF.md) - 2020-12-31 to 2021-12-31 | operating_income | -32,002,000 United States dollar | superseded | [clm_A8876813D031](/claim/clm_A8876813D031.md) - 2020-12-31 to 2021-03-31 | total_equity | 152,099,000 United States dollar | superseded | [clm_B5D7AE0B75C0](/claim/clm_B5D7AE0B75C0.md) - 2020-12-31 to 2021-12-31 | research_and_development | 30,491,000 United States dollar | superseded | [clm_DDB093202988](/claim/clm_DDB093202988.md) ## 2021 - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 102,303,000 United States dollar | superseded | [clm_2D8569E9730E](/claim/clm_2D8569E9730E.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | -6,367,000 United States dollar | superseded | [clm_5986C310904D](/claim/clm_5986C310904D.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 8,272,000 United States dollar | superseded | [clm_5C3369CD746D](/claim/clm_5C3369CD746D.md) - 2021-03-31 to 2021-06-30 | total_assets | 241,193,000 United States dollar | superseded | [clm_8C1BCC2F1986](/claim/clm_8C1BCC2F1986.md) - 2021-03-31 to 2021-06-30 | total_equity | 150,409,000 United States dollar | superseded | [clm_9E31EE900D3D](/claim/clm_9E31EE900D3D.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | -6,219,000 United States dollar | superseded | [clm_B88315B335AB](/claim/clm_B88315B335AB.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 40,818,000 United States dollar | superseded | [clm_FDF49B45A334](/claim/clm_FDF49B45A334.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | -5,442,000 United States dollar | superseded | [clm_3B805117D283](/claim/clm_3B805117D283.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 108,257,000 United States dollar | superseded | [clm_80B816DDE011](/claim/clm_80B816DDE011.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | -5,312,000 United States dollar | superseded | [clm_8EA4AA1012FB](/claim/clm_8EA4AA1012FB.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 44,685,000 United States dollar | superseded | [clm_C9290E12202A](/claim/clm_C9290E12202A.md) - 2021-06-30 to 2021-09-30 | total_assets | 245,625,000 United States dollar | superseded | [clm_D5499DAE155E](/claim/clm_D5499DAE155E.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 9,008,000 United States dollar | superseded | [clm_DEF7D62360EE](/claim/clm_DEF7D62360EE.md) - 2021-06-30 to 2021-09-30 | total_equity | 150,162,000 United States dollar | superseded | [clm_FC62B1C684AA](/claim/clm_FC62B1C684AA.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | -6,838,000 United States dollar | superseded | [clm_0EB9CBC7CA88](/claim/clm_0EB9CBC7CA88.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 49,091,000 United States dollar | superseded | [clm_7941FB4E120A](/claim/clm_7941FB4E120A.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 115,332,000 United States dollar | superseded | [clm_89BD18A26880](/claim/clm_89BD18A26880.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | -6,993,000 United States dollar | superseded | [clm_A1974FF4F170](/claim/clm_A1974FF4F170.md) - 2021-09-30 to 2021-12-31 | total_equity | 147,952,000 United States dollar | superseded | [clm_A3DE8E2082E0](/claim/clm_A3DE8E2082E0.md) - 2021-09-30 to 2021-12-31 | total_assets | 250,647,000 United States dollar | superseded | [clm_E6F190CCC9C4](/claim/clm_E6F190CCC9C4.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 10,551,000 United States dollar | superseded | [clm_F5ACD74FD4BB](/claim/clm_F5ACD74FD4BB.md) - 2021-12-31 to 2022-12-31 | operating_income | -28,089,000 United States dollar | superseded | [clm_53CDF8723E3B](/claim/clm_53CDF8723E3B.md) - 2021-12-31 to 2022-12-31 | revenue | 187,859,000 United States dollar | superseded | [clm_800253348298](/claim/clm_800253348298.md) - 2021-12-31 to 2022-03-31 | total_equity | 145,210,000 United States dollar | superseded | [clm_CFE1337838BD](/claim/clm_CFE1337838BD.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 107,114,000 United States dollar | superseded | [clm_D025474E50DA](/claim/clm_D025474E50DA.md) - 2021-12-31 to 2022-03-31 | total_assets | 264,717,000 United States dollar | superseded | [clm_E273A6BEEE33](/claim/clm_E273A6BEEE33.md) - 2021-12-31 to 2022-12-31 | net_income | -28,702,000 United States dollar | superseded | [clm_F9C8BDB56B2F](/claim/clm_F9C8BDB56B2F.md) - 2021-12-31 to 2022-12-31 | research_and_development | 40,049,000 United States dollar | superseded | [clm_FE0B851094D1](/claim/clm_FE0B851094D1.md) ## 2022 - 2022-03-31 to 2022-06-30 | quarterly_revenue | 57,429,000 United States dollar | superseded | [clm_0719C4C1F729](/claim/clm_0719C4C1F729.md) - 2022-03-31 to 2022-06-30 | total_equity | 142,754,000 United States dollar | superseded | [clm_3583CFE4CD9E](/claim/clm_3583CFE4CD9E.md) - 2022-03-31 to 2022-06-30 | total_assets | 270,487,000 United States dollar | superseded | [clm_4A7E60B993F1](/claim/clm_4A7E60B993F1.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 13,065,000 United States dollar | superseded | [clm_B58B680F4156](/claim/clm_B58B680F4156.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 81,662,000 United States dollar | superseded | [clm_C94DB63543E4](/claim/clm_C94DB63543E4.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | -9,755,000 United States dollar | superseded | [clm_CFCFA4371DD6](/claim/clm_CFCFA4371DD6.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -9,609,000 United States dollar | superseded | [clm_FE46C3B8B3E0](/claim/clm_FE46C3B8B3E0.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 15,374,000 United States dollar | superseded | [clm_45FD7F38F737](/claim/clm_45FD7F38F737.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -14,610,000 United States dollar | superseded | [clm_484E85E39561](/claim/clm_484E85E39561.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 68,561,000 United States dollar | superseded | [clm_4F945480E5F5](/claim/clm_4F945480E5F5.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -14,533,000 United States dollar | superseded | [clm_72EBD62A7DA7](/claim/clm_72EBD62A7DA7.md) - 2022-06-30 to 2022-09-30 | total_assets | 275,347,000 United States dollar | superseded | [clm_847D5F372FF9](/claim/clm_847D5F372FF9.md) - 2022-06-30 to 2022-09-30 | total_equity | 141,063,000 United States dollar | superseded | [clm_C1F55DF761E2](/claim/clm_C1F55DF761E2.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 61,432,000 United States dollar | superseded | [clm_E84FF1119174](/claim/clm_E84FF1119174.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -13,933,000 United States dollar | superseded | [clm_0E30AE816B9C](/claim/clm_0E30AE816B9C.md) - 2022-09-30 to 2022-12-31 | total_equity | 139,685,000 United States dollar | superseded | [clm_3F8C3A0C8E04](/claim/clm_3F8C3A0C8E04.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 65,307,000 United States dollar | superseded | [clm_5C354A4D9BED](/claim/clm_5C354A4D9BED.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 16,278,000 United States dollar | superseded | [clm_91E9CD491946](/claim/clm_91E9CD491946.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 95,141,000 United States dollar | superseded | [clm_A6BBFF824FB1](/claim/clm_A6BBFF824FB1.md) - 2022-09-30 to 2022-12-31 | total_assets | 278,522,000 United States dollar | superseded | [clm_C4C512372045](/claim/clm_C4C512372045.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -14,385,000 United States dollar | superseded | [clm_EB7054B45CFB](/claim/clm_EB7054B45CFB.md) - 2022-12-31 to 2023-12-31 | operating_income | -51,676,000 United States dollar | superseded | [clm_21B19DEFA679](/claim/clm_21B19DEFA679.md) - 2022-12-31 to 2023-12-31 | net_income | -50,240,000 United States dollar | superseded | [clm_7DF70EE97FB2](/claim/clm_7DF70EE97FB2.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 79,917,000 United States dollar | superseded | [clm_857AEF08186D](/claim/clm_857AEF08186D.md) - 2022-12-31 to 2023-03-31 | total_equity | 142,337,000 United States dollar | superseded | [clm_9311310C5FE4](/claim/clm_9311310C5FE4.md) - 2022-12-31 to 2023-12-31 | revenue | 253,828,000 United States dollar | superseded | [clm_BC54A6E768BE](/claim/clm_BC54A6E768BE.md) - 2022-12-31 to 2023-12-31 | research_and_development | 61,436,000 United States dollar | superseded | [clm_E3092FC4C976](/claim/clm_E3092FC4C976.md) - 2022-12-31 to 2023-03-31 | total_assets | 293,920,000 United States dollar | superseded | [clm_F7D6AA8AED2F](/claim/clm_F7D6AA8AED2F.md) ## 2023 - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 78,411,000 United States dollar | superseded | [clm_0C73D1A77237](/claim/clm_0C73D1A77237.md) - 2023-03-31 to 2023-06-30 | total_equity | 144,768,000 United States dollar | superseded | [clm_1C281D5639A8](/claim/clm_1C281D5639A8.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 75,212,000 United States dollar | superseded | [clm_5F66F97912D1](/claim/clm_5F66F97912D1.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 17,876,000 United States dollar | superseded | [clm_7A88B7E3A98E](/claim/clm_7A88B7E3A98E.md) - 2023-03-31 to 2023-06-30 | total_assets | 309,630,000 United States dollar | superseded | [clm_89CB8D51572C](/claim/clm_89CB8D51572C.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | -10,252,000 United States dollar | superseded | [clm_936E1B62C190](/claim/clm_936E1B62C190.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | -11,933,000 United States dollar | superseded | [clm_CC9622D83B51](/claim/clm_CC9622D83B51.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | -13,085,000 United States dollar | superseded | [clm_27C1277F2CD6](/claim/clm_27C1277F2CD6.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 74,365,000 United States dollar | superseded | [clm_379C8726C587](/claim/clm_379C8726C587.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 18,956,000 United States dollar | superseded | [clm_43C07BAA419D](/claim/clm_43C07BAA419D.md) - 2023-06-30 to 2023-09-30 | total_assets | 324,475,000 United States dollar | superseded | [clm_A21E7A47CCBE](/claim/clm_A21E7A47CCBE.md) - 2023-06-30 to 2023-09-30 | total_equity | 149,142,000 United States dollar | superseded | [clm_CC2068E90B91](/claim/clm_CC2068E90B91.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | -14,917,000 United States dollar | superseded | [clm_E1E377FC4E10](/claim/clm_E1E377FC4E10.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 79,315,000 United States dollar | superseded | [clm_EA2923357F1D](/claim/clm_EA2923357F1D.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | -24,204,000 United States dollar | superseded | [clm_0A31953C45C3](/claim/clm_0A31953C45C3.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 41,103,000 United States dollar | superseded | [clm_0E4B3A73EF2A](/claim/clm_0E4B3A73EF2A.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 85,532,000 United States dollar | superseded | [clm_1899A80F6755](/claim/clm_1899A80F6755.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | -23,013,000 United States dollar | superseded | [clm_48C43E389956](/claim/clm_48C43E389956.md) - 2023-09-30 to 2023-12-31 | total_equity | 144,944,000 United States dollar | superseded | [clm_77A7FE92B6D6](/claim/clm_77A7FE92B6D6.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 20,057,000 United States dollar | superseded | [clm_9584B061B9DE](/claim/clm_9584B061B9DE.md) - 2023-09-30 to 2023-12-31 | total_assets | 400,313,000 United States dollar | superseded | [clm_B82A6B128F75](/claim/clm_B82A6B128F75.md) - 2023-12-31 to 2024-03-31 | total_assets | 396,585,000 United States dollar | superseded | [clm_062A678BB68A](/claim/clm_062A678BB68A.md) - 2023-12-31 to 2024-12-31 | revenue | 333,643,000 United States dollar | superseded | [clm_82AB2CDAD7AB](/claim/clm_82AB2CDAD7AB.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 49,760,000 United States dollar | superseded | [clm_9B1A6E49127B](/claim/clm_9B1A6E49127B.md) - 2023-12-31 to 2024-03-31 | total_equity | 144,192,000 United States dollar | superseded | [clm_BBC2CDA56B0D](/claim/clm_BBC2CDA56B0D.md) - 2023-12-31 to 2024-12-31 | operating_income | -69,277,000 United States dollar | superseded | [clm_C05C195C52BA](/claim/clm_C05C195C52BA.md) - 2023-12-31 to 2024-12-31 | net_income | -66,427,000 United States dollar | superseded | [clm_CDE778EA845E](/claim/clm_CDE778EA845E.md) - 2023-12-31 to 2024-12-31 | research_and_development | 79,550,000 United States dollar | superseded | [clm_F11498A69C1F](/claim/clm_F11498A69C1F.md) ## 2024 - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 69,162,000 United States dollar | superseded | [clm_15E6383C2A4E](/claim/clm_15E6383C2A4E.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | -13,575,000 United States dollar | superseded | [clm_1A34D2511625](/claim/clm_1A34D2511625.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 96,784,000 United States dollar | superseded | [clm_30A95E2F9E5A](/claim/clm_30A95E2F9E5A.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | -13,287,000 United States dollar | superseded | [clm_8640AEFE3E00](/claim/clm_8640AEFE3E00.md) - 2024-03-31 to 2024-06-30 | total_assets | 389,940,000 United States dollar | superseded | [clm_A616881DFB6D](/claim/clm_A616881DFB6D.md) - 2024-03-31 to 2024-06-30 | total_equity | 147,350,000 United States dollar | superseded | [clm_C5A48736E101](/claim/clm_C5A48736E101.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 23,769,000 United States dollar | superseded | [clm_D5955B103F58](/claim/clm_D5955B103F58.md) - 2024-06-30 to 2024-09-30 | total_assets | 393,601,000 United States dollar | superseded | [clm_0F9052FC5944](/claim/clm_0F9052FC5944.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 25,126,000 United States dollar | superseded | [clm_197BACE8D302](/claim/clm_197BACE8D302.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 80,873,000 United States dollar | superseded | [clm_5AC328BA4C96](/claim/clm_5AC328BA4C96.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | -16,892,000 United States dollar | superseded | [clm_7EA5271DB248](/claim/clm_7EA5271DB248.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | -16,513,000 United States dollar | superseded | [clm_B8B59B035C75](/claim/clm_B8B59B035C75.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 99,396,000 United States dollar | superseded | [clm_E00950F61997](/claim/clm_E00950F61997.md) - 2024-06-30 to 2024-09-30 | total_equity | 152,123,000 United States dollar | superseded | [clm_FF9932026C11](/claim/clm_FF9932026C11.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 82,886,000 United States dollar | superseded | [clm_0ABD6889A432](/claim/clm_0ABD6889A432.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | -16,879,000 United States dollar | superseded | [clm_298AF49509D0](/claim/clm_298AF49509D0.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 102,638,000 United States dollar | superseded | [clm_30DEC94410A6](/claim/clm_30DEC94410A6.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | -17,087,000 United States dollar | superseded | [clm_7B285A48D3C6](/claim/clm_7B285A48D3C6.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 26,272,000 United States dollar | superseded | [clm_A03D0D30C84F](/claim/clm_A03D0D30C84F.md) - 2024-09-30 to 2024-12-31 | total_equity | 158,086,000 United States dollar | superseded | [clm_B2A5ACCFCBC4](/claim/clm_B2A5ACCFCBC4.md) - 2024-09-30 to 2024-12-31 | total_assets | 388,829,000 United States dollar | superseded | [clm_C4E74C510430](/claim/clm_C4E74C510430.md) - 2024-09-30 | chair | Justyn Howard | valid | [clm_E2BA6BA5A1B2](/claim/clm_E2BA6BA5A1B2.md) - 2024-10-01 | ceo | Ryan Barretto | valid | [clm_0E265C50FECF](/claim/clm_0E265C50FECF.md) - 2024-10-01 | board_member | Ryan Barretto | valid | [clm_4AD1360307ED](/claim/clm_4AD1360307ED.md) - 2024-12-31 to 2025-12-31 | net_income | -61,971,000 United States dollar | superseded | [clm_082841F2578D](/claim/clm_082841F2578D.md) - 2024-12-31 to 2025-12-31 | revenue | 405,908,000 United States dollar | superseded | [clm_0CAC947D53EE](/claim/clm_0CAC947D53EE.md) - 2024-12-31 to 2025-03-31 | total_assets | 428,341,000 United States dollar | superseded | [clm_14EE90507141](/claim/clm_14EE90507141.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 86,437,000 United States dollar | superseded | [clm_1C5B32C30D2B](/claim/clm_1C5B32C30D2B.md) - 2024-12-31 to 2025-03-31 | total_equity | 166,594,000 United States dollar | superseded | [clm_269996A19407](/claim/clm_269996A19407.md) - 2024-12-31 to 2025-12-31 | research_and_development | 102,794,000 United States dollar | superseded | [clm_27557DD2796C](/claim/clm_27557DD2796C.md) - 2024-12-31 to 2025-12-31 | operating_income | -60,356,000 United States dollar | superseded | [clm_3F434FA35ECC](/claim/clm_3F434FA35ECC.md) ## 2025 - 2025-03-31 to 2025-06-30 | quarterly_operating_income | -11,202,000 United States dollar | superseded | [clm_1075403A62BB](/claim/clm_1075403A62BB.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 100,902,000 United States dollar | superseded | [clm_66E316092842](/claim/clm_66E316092842.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 109,289,000 United States dollar | superseded | [clm_921B2AD3356A](/claim/clm_921B2AD3356A.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 23,229,000 United States dollar | superseded | [clm_A89ACD126A46](/claim/clm_A89ACD126A46.md) - 2025-03-31 to 2025-06-30 | total_assets | 424,657,000 United States dollar | superseded | [clm_D37EB8D8A56B](/claim/clm_D37EB8D8A56B.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | -11,220,000 United States dollar | superseded | [clm_E76B9A71C877](/claim/clm_E76B9A71C877.md) - 2025-03-31 to 2025-06-30 | total_equity | 175,309,000 United States dollar | superseded | [clm_FD203E090B78](/claim/clm_FD203E090B78.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 101,532,000 United States dollar | superseded | [clm_0C6A3DC6A705](/claim/clm_0C6A3DC6A705.md) - 2025-06-30 to 2025-09-30 | total_assets | 422,934,000 United States dollar | superseded | [clm_1AA31CD16440](/claim/clm_1AA31CD16440.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | -11,985,000 United States dollar | superseded | [clm_441891C66356](/claim/clm_441891C66356.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | -12,315,000 United States dollar | superseded | [clm_4AA363FFC2F1](/claim/clm_4AA363FFC2F1.md) - 2025-06-30 to 2025-09-30 | total_equity | 184,559,000 United States dollar | superseded | [clm_6CE62957FD01](/claim/clm_6CE62957FD01.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 24,587,000 United States dollar | superseded | [clm_843EC13C329F](/claim/clm_843EC13C329F.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 111,778,000 United States dollar | superseded | [clm_C23AB394CA35](/claim/clm_C23AB394CA35.md) - 2025-07-30 | acquired | NewsWhip Group Holdings Limited | valid | [clm_3401A1C1CDDE](/claim/clm_3401A1C1CDDE.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | -9,111,000 United States dollar | superseded | [clm_0A07A8486E51](/claim/clm_0A07A8486E51.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | -9,381,000 United States dollar | superseded | [clm_3E5C4F6C72F2](/claim/clm_3E5C4F6C72F2.md) - 2025-09-30 to 2025-12-31 | total_equity | 194,126,000 United States dollar | superseded | [clm_5BF1402FAAC0](/claim/clm_5BF1402FAAC0.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 115,593,000 United States dollar | superseded | [clm_635A38BA8DF1](/claim/clm_635A38BA8DF1.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 25,068,000 United States dollar | superseded | [clm_E0A9A06B20B3](/claim/clm_E0A9A06B20B3.md) - 2025-09-30 to 2025-12-31 | total_assets | 481,396,000 United States dollar | superseded | [clm_EDCFF5D878C4](/claim/clm_EDCFF5D878C4.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 90,639,000 United States dollar | superseded | [clm_FA294419519D](/claim/clm_FA294419519D.md) - 2025-11-11 | board_member | Gregory Scott Brown | valid | [clm_EA6F238BA161](/claim/clm_EA6F238BA161.md) - 2025-12-31 to 2026-03-31 | total_equity | 203,422,000 United States dollar | superseded | [clm_13482DAA5E58](/claim/clm_13482DAA5E58.md) - 2025-12-31 | employees | 1,362 | valid | [clm_76EDD543D3D4](/claim/clm_76EDD543D3D4.md) - 2025-12-31 to 2026-03-31 | total_assets | 523,062,000 United States dollar | superseded | [clm_8389C627EE55](/claim/clm_8389C627EE55.md) - 2025-12-31 | research_and_development | 101,279,000 United States dollar | valid | [clm_8500220BE76C](/claim/clm_8500220BE76C.md) - 2025-12-31 | net_income | -43,327,000 United States dollar | valid | [clm_895687E44EC4](/claim/clm_895687E44EC4.md) - 2025-12-31 | revenue | 457,547,000 United States dollar | valid | [clm_8D8BA2B83CF2](/claim/clm_8D8BA2B83CF2.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 95,268,000 United States dollar | superseded | [clm_D980A937F9ED](/claim/clm_D980A937F9ED.md) - 2025-12-31 | operating_income | -43,453,000 United States dollar | valid | [clm_FEA6A335A9F7](/claim/clm_FEA6A335A9F7.md) ## 2026 - 2026-03-11 | cfo | Ryan Barretto | valid | [clm_5826F44C7BE0](/claim/clm_5826F44C7BE0.md) - 2026-03-31 to 2026-06-30 | total_equity | 215,190,000 United States dollar | superseded | [clm_0607BEE4853D](/claim/clm_0607BEE4853D.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 26,947,000 United States dollar | superseded | [clm_2CEB1A4E5E8C](/claim/clm_2CEB1A4E5E8C.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 121,497,000 United States dollar | superseded | [clm_3A39BC112E11](/claim/clm_3A39BC112E11.md) - 2026-03-31 to 2026-06-30 | total_assets | 508,598,000 United States dollar | superseded | [clm_3B7CF885EBF8](/claim/clm_3B7CF885EBF8.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 111,620,000 United States dollar | superseded | [clm_59D2ADC03577](/claim/clm_59D2ADC03577.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | -6,336,000 United States dollar | superseded | [clm_6C58657F7966](/claim/clm_6C58657F7966.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | -5,846,000 United States dollar | superseded | [clm_CF5C15173A76](/claim/clm_CF5C15173A76.md) - 2026-06-30 | cash_and_equivalents | 119,929,000 United States dollar | valid | [clm_0999178FFF80](/claim/clm_0999178FFF80.md) - 2026-06-30 | total_equity | 228,550,000 United States dollar | valid | [clm_3DDE76F79B9D](/claim/clm_3DDE76F79B9D.md) - 2026-06-30 | quarterly_net_income | -3,089,000 United States dollar | valid | [clm_4EE11FF31185](/claim/clm_4EE11FF31185.md) - 2026-06-30 | total_assets | 522,215,000 United States dollar | valid | [clm_542C75E035DF](/claim/clm_542C75E035DF.md) - 2026-06-30 | quarterly_research_and_development | 26,643,000 United States dollar | valid | [clm_6330ECB4B417](/claim/clm_6330ECB4B417.md) - 2026-06-30 | quarterly_operating_income | -2,669,000 United States dollar | valid | [clm_D9F19AC0CCA7](/claim/clm_D9F19AC0CCA7.md) - 2026-06-30 | quarterly_revenue | 123,847,000 United States dollar | valid | [clm_DD2AE91746EB](/claim/clm_DD2AE91746EB.md) - 2026-07-08 | restructuring | Approximately 20% workforce reduction, about 260 employees, aligning cost base | valid | [clm_08F8124D5A85](/claim/clm_08F8124D5A85.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.